Trial Profile
Patient-Reported Outcomes With Etoricoxib in Real Life.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Etoricoxib (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Organon
- 16 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Oct 2008 New trial record.